Tradestie Institutional Equity Comparison Engine

BIIB vs ATHA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BIIB Overall Edge

BIIB Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biogen Inc. Common Stock (BIIB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BIIB trades at 15.6x Forward P/E with 23.5% operating margin (+10.6% YoY revenue) versus ATHA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BIIB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ATHA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BIIB
BIIB 15.6x vs ATHA N/M Fwd P/E
Growth & Margin Winner BIIB
Op Margin 23.5% vs 0.0% ยท YoY +10.6% vs +0.0%
Momentum & Technical Winner BIIB
1Y +53.4% vs +12.5% ยท 52W Pos 92% vs 80%
Options & Structure Winner BIIB
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
BIIB NASDAQ
Biogen Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$252.72
-0.27% 1D
Market Cap $37.0B
1M Return +8.63%
1Y Return +53.41%
Forward P/E 15.6x
Unified AI Score
50.2 / 100 HOLD
Tech 45.0 Fund 52.0 Flow 64.0 Mom 50.0
ATHA NASDAQ
Athira Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$6.75
-6.12% 1D
Market Cap $26.6M
1M Return +73.75%
1Y Return +12.5%
Forward P/E N/M
Unified AI Score
56.2 / 100 HOLD
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIIB +53.41% ATHA +12.5% Spread: +29.87 pp (ATHA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIIB TTM Op. Margin: 23.5% ATHA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIIB vs ATHA. Trailing 12-month operating profitability (BIIB 23.5% vs ATHA 0.0%) and valuation multiples (BIIB 15.6x vs ATHA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIIB (9) vs ATHA (1)
Institutional Metric BIIB ATHA Criterion Row Winner
Market Capitalization Scale $37.0B $26.6M Larger Scale BIIB
Trailing P/E Ratio Valuation 109.9x N/M Lower Multiple BIIB
Forward P/E Ratio Valuation 15.6x N/M Lower Multiple BIIB
Revenue Growth (YoY) Growth +10.6% +0.0% Higher Growth BIIB
Operating Margin (TTM) Profitability 23.5% 0.0% Higher Margin BIIB
Net Profit Margin Profitability 3.4% 0.0% Higher Margin BIIB
Return on Equity (ROE) Capital Efficiency 1.9% -89.4% Higher ROE BIIB
52-Week Range Position Momentum 92% ($160โ€“$261) 80% ($0โ€“$8) Stronger Trend BIIB
Beta / 30D Volatility Risk Regime 0.27ฮฒ ยท 36% Vol 6.17ฮฒ ยท 241% Vol Lower Realized Risk BIIB
Unified Institutional Score Composite Signal 50.2 / 100 (HOLD) 56.2 / 100 (HOLD) Higher Composite ATHA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIIB vs ATHA Buy Guide
BIIB CONSOLIDATION
17d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live BIIB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATHA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ATHA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIIB nor ATHA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.